Gpr65-IRES-Cre

Nomenclature

C57BL/6Smoc-Gpr65em1(IRES-iCre)Smoc

Cat. NO.

NM-KI-200135

Strain State

Sperm cryopreservation

Export PDF

Gene Summary

Gene Symbol
Gpr65

Synonyms

Dig1; TDAG8; Gpcr25

Chromosome

12

NCBI ID

14744

MGI ID

108031

Ensembl ID

ENSMUSG00000021886

Pubmed

Gpr65

Model Description

A IRES-iCre expression cassette was knocked into the Gpr65 gene stop codon site.
Research Application：Cre recombinase tool; The G-protein-coupled receptor(GPR65) neurons  innervate intestinal villi and gastric mucosa to sense nutrients. When crossed with a strain carrying a gene flanked by loxP sites, the flanked gene will be removed in cells expressing cre.

Validation Data

image.png

Fig. 1 Cre-mediated recombination in the intestine of Gpr65Cre/+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the large intestine and small intestine derived from Gpr65Cre/+; Rosa26tdTomato/+ mouse.

image.png

Fig. 2 Detection of tdTomato(red) in various tissues of Gpr65Cre/+; Rosa26tdTomato/+ mice. Cre mediated recombination can be detected in the pituitary gland, heart, liver, lung, stomach, salivary gland, kidney, pancreas, large intestine, skin, testis and epididymis. TdTomato can also be detected in individual cells of the thymus and spleen. Tdtomato expression can not be observed in brown fat. (For more detailed information please contact our technical advisor.)


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more